#term ID	term description	observed gene count	background gene count	strength	signal	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
WP69	T-cell receptor signaling pathway	8	90	1.24	1.16	2.69e-05	9606.ENSP00000221930,9606.ENSP00000338171,9606.ENSP00000339186,9606.ENSP00000345492,9606.ENSP00000346300,9606.ENSP00000378845,9606.ENSP00000385675,9606.ENSP00000478699	TGFB1,SKAP1,GRAP2,SH2B3,CRKL,LAT,IL6,TNFRSF9
WP5078	T cell modulation in pancreatic cancer	6	45	1.42	1.11	8.35e-05	9606.ENSP00000221930,9606.ENSP00000349446,9606.ENSP00000361359,9606.ENSP00000385675,9606.ENSP00000412237,9606.ENSP00000478699	TGFB1,ARG1,CD40,IL6,IL10,TNFRSF9
WP4298	Acute viral myocarditis	7	85	1.21	1.02	0.00011	9606.ENSP00000221930,9606.ENSP00000311032,9606.ENSP00000362680,9606.ENSP00000385675,9606.ENSP00000412237,9606.ENSP00000416255,9606.ENSP00000442600	TGFB1,CASP3,SRC,IL6,IL10,EIF4G1,DAG1
WP5095	Overview of proinflammatory and profibrotic mediators	7	126	1.04	0.76	0.00098	9606.ENSP00000221930,9606.ENSP00000263851,9606.ENSP00000296026,9606.ENSP00000354901,9606.ENSP00000378517,9606.ENSP00000385675,9606.ENSP00000412237	TGFB1,IL7,CXCL3,CXCL9,SPP1,IL6,IL10
WP2328	Allograft rejection	6	88	1.13	0.75	0.0013	9606.ENSP00000221930,9606.ENSP00000311032,9606.ENSP00000354901,9606.ENSP00000361359,9606.ENSP00000363773,9606.ENSP00000412237	TGFB1,CASP3,CXCL9,CD40,C1QA,IL10
WP530	Cytokines and inflammatory response	4	26	1.48	0.76	0.0020	9606.ENSP00000221930,9606.ENSP00000263851,9606.ENSP00000385675,9606.ENSP00000412237	TGFB1,IL7,IL6,IL10
WP5115	Network map of SARS-CoV-2 signaling pathway	8	218	0.86	0.64	0.0021	9606.ENSP00000263851,9606.ENSP00000296026,9606.ENSP00000311032,9606.ENSP00000338171,9606.ENSP00000354901,9606.ENSP00000385675,9606.ENSP00000391592,9606.ENSP00000412237	IL7,CXCL3,CASP3,SKAP1,CXCL9,IL6,PTPN6,IL10
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	5	62	1.2	0.71	0.0022	9606.ENSP00000339186,9606.ENSP00000378845,9606.ENSP00000391592,9606.ENSP00000412237,9606.ENSP00000442600	GRAP2,LAT,PTPN6,IL10,DAG1
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	5	66	1.17	0.69	0.0026	9606.ENSP00000221930,9606.ENSP00000296026,9606.ENSP00000354901,9606.ENSP00000385675,9606.ENSP00000412237	TGFB1,CXCL3,CXCL9,IL6,IL10
WP4495	IL-10 anti-inflammatory signaling pathway 	3	12	1.69	0.69	0.0043	9606.ENSP00000263368,9606.ENSP00000385675,9606.ENSP00000412237	BLVRB,IL6,IL10
WP3937	Microglia pathogen phagocytosis pathway	4	40	1.29	0.64	0.0051	9606.ENSP00000356505,9606.ENSP00000363773,9606.ENSP00000378845,9606.ENSP00000391592	NCF2,C1QA,LAT,PTPN6
WP4754	IL-18 signaling pathway	8	271	0.76	0.53	0.0056	9606.ENSP00000248553,9606.ENSP00000296026,9606.ENSP00000311032,9606.ENSP00000349446,9606.ENSP00000356505,9606.ENSP00000378517,9606.ENSP00000385675,9606.ENSP00000412237	HSPB1,CXCL3,CASP3,ARG1,NCF2,SPP1,IL6,IL10
WP4891	COVID-19 adverse outcome pathway	3	15	1.6	0.65	0.0058	9606.ENSP00000263851,9606.ENSP00000385675,9606.ENSP00000412237	IL7,IL6,IL10
WP286	IL-3 signaling pathway	4	49	1.21	0.58	0.0077	9606.ENSP00000221930,9606.ENSP00000346300,9606.ENSP00000362680,9606.ENSP00000391592	TGFB1,CRKL,SRC,PTPN6
WP3646	Hepatitis C and hepatocellular carcinoma	4	48	1.22	0.58	0.0077	9606.ENSP00000221930,9606.ENSP00000311032,9606.ENSP00000384849,9606.ENSP00000385675	TGFB1,CASP3,CDKN1A,IL6
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	4	53	1.17	0.56	0.0088	9606.ENSP00000248553,9606.ENSP00000262320,9606.ENSP00000321326,9606.ENSP00000384849	HSPB1,AXIN1,F2R,CDKN1A
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3	19	1.49	0.59	0.0088	9606.ENSP00000248553,9606.ENSP00000378517,9606.ENSP00000385675	HSPB1,SPP1,IL6
WP4747	Netrin-UNC5B signaling pathway	4	52	1.18	0.56	0.0088	9606.ENSP00000311032,9606.ENSP00000362680,9606.ENSP00000380942,9606.ENSP00000412237	CASP3,SRC,ARHGEF12,IL10
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4	55	1.16	0.56	0.0093	9606.ENSP00000221930,9606.ENSP00000262320,9606.ENSP00000378517,9606.ENSP00000384849	TGFB1,AXIN1,SPP1,CDKN1A
WP5072	Modulators of TCR signaling and T cell activation	4	61	1.11	0.52	0.0128	9606.ENSP00000339186,9606.ENSP00000345492,9606.ENSP00000378845,9606.ENSP00000391592	GRAP2,SH2B3,LAT,PTPN6
WP2431	Spinal cord injury	5	115	0.93	0.49	0.0133	9606.ENSP00000221930,9606.ENSP00000285735,9606.ENSP00000311032,9606.ENSP00000349446,9606.ENSP00000385675	TGFB1,RHOC,CASP3,ARG1,IL6
WP3888	VEGFA-VEGFR2 signaling	9	428	0.62	0.43	0.0133	9606.ENSP00000248553,9606.ENSP00000285735,9606.ENSP00000356436,9606.ENSP00000356505,9606.ENSP00000362680,9606.ENSP00000376367,9606.ENSP00000391592,9606.ENSP00000407685,9606.ENSP00000416255	HSPB1,RHOC,PLA2G4A,NCF2,SRC,WASF1,PTPN6,TNXB,EIF4G1
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	4	72	1.04	0.46	0.0202	9606.ENSP00000221930,9606.ENSP00000262320,9606.ENSP00000311032,9606.ENSP00000384849	TGFB1,AXIN1,CASP3,CDKN1A
WP366	TGF-beta signaling pathway	5	132	0.87	0.43	0.0213	9606.ENSP00000221930,9606.ENSP00000262320,9606.ENSP00000313391,9606.ENSP00000362680,9606.ENSP00000384849	TGFB1,AXIN1,DAB2,SRC,CDKN1A
WP2037	Prolactin signaling pathway	4	76	1.02	0.45	0.0226	9606.ENSP00000300026,9606.ENSP00000311032,9606.ENSP00000362680,9606.ENSP00000391592	PPIB,CASP3,SRC,PTPN6
WP5088	Prostaglandin signaling	3	32	1.27	0.47	0.0226	9606.ENSP00000221930,9606.ENSP00000354901,9606.ENSP00000385675	TGFB1,CXCL9,IL6
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	5	143	0.84	0.41	0.0269	9606.ENSP00000233154,9606.ENSP00000311032,9606.ENSP00000356505,9606.ENSP00000362680,9606.ENSP00000378517	NCK2,CASP3,NCF2,SRC,SPP1
WP4666	Hepatitis B infection	5	150	0.82	0.39	0.0318	9606.ENSP00000221930,9606.ENSP00000311032,9606.ENSP00000362680,9606.ENSP00000384849,9606.ENSP00000385675	TGFB1,CASP3,SRC,CDKN1A,IL6
WP5285	Immune infiltration in pancreatic cancer	3	38	1.19	0.42	0.0318	9606.ENSP00000221930,9606.ENSP00000385675,9606.ENSP00000412237	TGFB1,IL6,IL10
WP2828	Bladder cancer	3	39	1.18	0.42	0.0324	9606.ENSP00000362680,9606.ENSP00000379038,9606.ENSP00000384849	SRC,TYMP,CDKN1A
WP3941	Oxidative damage response	3	39	1.18	0.42	0.0324	9606.ENSP00000311032,9606.ENSP00000363773,9606.ENSP00000384849	CASP3,C1QA,CDKN1A
WP673	ErbB signaling pathway	4	89	0.95	0.4	0.0324	9606.ENSP00000233154,9606.ENSP00000346300,9606.ENSP00000362680,9606.ENSP00000384849	NCK2,CRKL,SRC,CDKN1A
WP4136	Fibrin complement receptor 3 signaling pathway	3	43	1.14	0.4	0.0384	9606.ENSP00000296026,9606.ENSP00000362680,9606.ENSP00000385675	CXCL3,SRC,IL6
WP5198	Inflammatory bowel disease signaling	3	43	1.14	0.4	0.0384	9606.ENSP00000221930,9606.ENSP00000385675,9606.ENSP00000412237	TGFB1,IL6,IL10
WP2586	Aryl hydrocarbon receptor pathway	3	45	1.12	0.39	0.0409	9606.ENSP00000295256,9606.ENSP00000362680,9606.ENSP00000384849	HPGDS,SRC,CDKN1A
WP75	Toll-like receptor signaling pathway	4	102	0.89	0.36	0.0445	9606.ENSP00000354901,9606.ENSP00000361359,9606.ENSP00000378517,9606.ENSP00000385675	CXCL9,CD40,SPP1,IL6
WP5090	Complement system in neuronal development and plasticity	4	105	0.88	0.35	0.0480	9606.ENSP00000221930,9606.ENSP00000258080,9606.ENSP00000311032,9606.ENSP00000363773	TGFB1,HTRA2,CASP3,C1QA
